companies that make glp 1 drugs The future of GLP-1 in healthcare: Vital's role in enhancing metabolic treatment programs Food companies are targeting users

Publication bias was assessed using Eggers test

28 The combination of multiple medications and/or the financial burden may be too much for some patients

Remember that prior to Wegovys FDA approval as a weight loss drug, Novo Nordisk promised their shareholders one of the fastest Novo Nordisk launches after approval ever.(Content note link contains significant weight stigma and diet culture content.) Again knowing that weight loss drugs create/exacerbate eating disorders and knowing that the weight loss industry is trying to create blockbuster drugs to fill their shareholders coffers, this was all entirely predictable and it should have been studied from the beginning, not the topic of a discussion about the lack of research now

Compounded Tirzepatide - According to the company, pricing starts at approximately $259 per month